PurificationAntibodies were produced from mice ascites by injecting mice with a monoclonal cell line which was fusioned by mouse spleen and SP2/0 myeloma cell. Spleen cells were isolated from mice by immunizing with synthetic peptide and KLH conjugates.
ApplicationsWB
Species ReactivityHu
SpecificityThis mouse mAb only detects transfected proteins.
Immunogen TypePeptide-KLH
Immunogen DescriptionPeptide sequence derived from C-terminal (aa. 410-432) of human c-Myc conjugated with KLH.
StorageStore at 4°C for short term use. Store at -20°C for long term preservation. Avoid freezing and thawing repeatly.
Application Details
Predicted MW: 60kd
Western blotting: 1:500~1:1000
Images
Western blot analysis of extracts from 293 cells transfected with recombinant human Myc using Myc mouse mAb #AB21390.
Background
Myc proto-oncogene encodes nuclear DNA-binding phosphoproteins that are involved in the regulation of gene expression and DNA replication during cell growth and differentiation. Myc encodes a protein of 65 kDa which is expressed in almost all normal and transformed cells. The expression correlates with the proliferation state of the cells. Transcription is repressed in quiescent or terminally differentiated cells. Expression of Myc is generally induced after mitogenic stimulation of cells or serum induction. Myc therefore is an important positive regulator of cell growth and proliferation. Myc has been demonstrated also to be a potent inducer of apoptosis when expressed in the absence of serum or growth factors. Apoptosis may serve also as a protective mechanism to prevent tumorigenicity elicited by deregulated Myc expression. Sequences of the Myc oncogene have been highly conserved throughout evolution, from Drosophila to vertebrates
Baudino T A, et al. (2001) Mol Cell Biol. 21: 691-702.
Blackwood E M, et al. (1991) Science. 251:1211-1217.
Henriksson M, et al. (1996) Adv Cancer Res. 68: 109-182.
Grandori C, et al. (2000) Annu Rev Cell Dev Biol. 16: 653-699.